Medicine recalls
|
| |
| Canada: Recall: Vitrakvi: Presence of contamination in affected lot |
| |
Health Canada announces that Bayer Inc. is recalling one lot of Vitrakvi Solution (larotrectinib 20mg/ml) (lot number: 2133134) from healthcare establishments due to presence of contamination in the affected lot.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/vitrakvi-presence-contamination-affected-lot
In Hong Kong, Vitrakvi Oral Solution 20mg/ml (HK-66493) is a pharmaceutical product registered by Bayer Healthcare Limited (Bayer). The product is a prescription-only medicine. As confirmed with Bayer, the affected lot has not been imported into Hong Kong.
Ends/Thursday, Nov 9, 2023
Issued at HKT 14:30
|
| |
|
